These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36934966)

  • 1. Evaluation of disk diffusion method for testing the rifampicin, erythromycin, and tetracycline susceptibility of Clostridioides (prev. Clostridium) difficile.
    Carvalho GM; Silva BA; Xavier RGC; Zanon IP; Vilela EG; Nicolino RR; Tavares GC; Silva ROS
    Anaerobe; 2023 Apr; 80():102720. PubMed ID: 36934966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility testing of Clostridium difficile using EUCAST epidemiological cut-off values and disk diffusion correlates.
    Erikstrup LT; Danielsen TK; Hall V; Olsen KE; Kristensen B; Kahlmeter G; Fuursted K; Justesen US
    Clin Microbiol Infect; 2012 Aug; 18(8):E266-72. PubMed ID: 22672504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile.
    Huhulescu S; Sagel U; Fiedler A; Pecavar V; Blaschitz M; Wewalka G; Allerberger F; Indra A
    J Med Microbiol; 2011 Aug; 60(Pt 8):1206-1212. PubMed ID: 21292853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Prevalence of Multidrug-Resistant
    Mutai WC; Mureithi MW; Anzala O; Revathi G; Kullin B; Burugu M; Kyany'a C; Odoyo E; Otieno P; Musila L
    Front Cell Infect Microbiol; 2020; 10():604986. PubMed ID: 33628744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial resistance progression in the United Kingdom: A temporal comparison of Clostridioides difficile antimicrobial susceptibilities.
    Jon J V; Mark H W; Jane F
    Anaerobe; 2021 Aug; 70():102385. PubMed ID: 34048922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between serogroup and susceptibility to chloramphenicol, clindamycin, erythromycin, rifampicin and tetracycline among 308 isolates of Clostridium difficile.
    Delmée M; Avesani V
    J Antimicrob Chemother; 1988 Sep; 22(3):325-31. PubMed ID: 3053559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility of Brazilian Clostridium difficile strains determined by agar dilution and disk diffusion.
    Fraga EG; Nicodemo AC; Sampaio JL
    Braz J Infect Dis; 2016; 20(5):476-81. PubMed ID: 27542867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In Vitro Activities of Antimicrobials Against Toxigenic Clostridioides difficile Isolates Obtained in a University Training and Research Hospital in Turkey].
    Sayın E; Bilgin H; Söyletir G; Ülger Toprak N
    Mikrobiyol Bul; 2020 Jul; 54(3):368-377. PubMed ID: 32755514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997.
    Barbut F; Decré D; Burghoffer B; Lesage D; Delisle F; Lalande V; Delmée M; Avesani V; Sano N; Coudert C; Petit JC
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2607-11. PubMed ID: 10543736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emergence of metronidazole and vancomycin reduced susceptibility in Clostridium difficile isolates in Iran.
    Kouhsari E; Douraghi M; Krutova M; Fakhre Yaseri H; Talebi M; Baseri Z; Moqarabzadeh V; Sholeh M; Amirmozafari N
    J Glob Antimicrob Resist; 2019 Sep; 18():28-33. PubMed ID: 30703583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dogs as carriers of virulent and resistant genotypes of Clostridioides difficile.
    Finsterwalder SK; Loncaric I; Cabal A; Szostak MP; Barf LM; Marz M; Allerberger F; Burgener IA; Tichy A; Feßler AT; Schwarz S; Monecke S; Ehricht R; Ruppitsch W; Spergser J; Künzel F
    Zoonoses Public Health; 2022 Sep; 69(6):673-681. PubMed ID: 35546073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spore-Forming
    Chisholm JM; Putsathit P; Riley TV; Lim SC
    Microbiol Spectr; 2023 Feb; 11(1):e0358222. PubMed ID: 36475924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, characteristics and antimicrobial susceptibility patterns of Clostridioides difficile isolated from hospitals in Iran.
    Alimolaei M; Rahimi HR; Ezatkhah M; Shamsaddini Bafti M; Afzali S
    J Glob Antimicrob Resist; 2019 Dec; 19():22-27. PubMed ID: 30825696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistance in European Clostridium difficile clinical isolates.
    Spigaglia P; Barbanti F; Mastrantonio P;
    J Antimicrob Chemother; 2011 Oct; 66(10):2227-34. PubMed ID: 21771851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interest of the disk diffusion method for screening Clostridium difficile isolates with decreased susceptibility to antibiotics].
    Poilane I; Bert F; Cruaud P; Nicolas-Chanoine MH; Collignon A
    Pathol Biol (Paris); 2007 Nov; 55(8-9):429-33. PubMed ID: 17905536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simplified method for testing Bordetella pertussis for resistance to erythromycin and other antimicrobial agents.
    Hill BC; Baker CN; Tenover FC
    J Clin Microbiol; 2000 Mar; 38(3):1151-5. PubMed ID: 10699011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular characters and antibiotic resistance of Clostridioides difficile from economic animals in China.
    Zhang WZ; Li WG; Liu YQ; Gu WP; Zhang Q; Li H; Liu ZJ; Zhang X; Wu Y; Lu JX
    BMC Microbiol; 2020 Mar; 20(1):70. PubMed ID: 32228454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017.
    Karlowsky JA; Adam HJ; Baxter MR; Dutka CW; Nichol KA; Laing NM; Golding GR; Zhanel GG
    J Antimicrob Chemother; 2020 Jul; 75(7):1824-1832. PubMed ID: 32294172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance in large clostridial toxin-negative, binary toxin-positive Clostridium difficile ribotypes.
    Androga GO; Knight DR; Lim SC; Foster NF; Riley TV
    Anaerobe; 2018 Dec; 54():55-60. PubMed ID: 30053486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18.
    Putsathit P; Hong S; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR
    J Antimicrob Chemother; 2021 Jun; 76(7):1815-1821. PubMed ID: 33895826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.